Nova’s (NASDAQ:NVMI) Q2 Sales Top Estimates, Inventory Levels Improve

Nova (NASDAQ:NVMI) reported Q2 CY2026 revenue of $255 million, up 15.9% year on year and 1.6% above estimates. Q3 guidance revenue was $282 million at the midpoint, 1.8% above consensus. Non-GAAP EPS was $2.51, 4.1% above estimates. Days inventory outstanding fell to 152, 30 days below its 5-year average.

Original reporting
Published Aug 6, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nova’s (NASDAQ:NVMI) Q2 Sales Top Estimates, Inventory Levels Improve — source image
Decision brief

The 30-second read

$NVMIBullishMed
01

Why it matters

Q2 revenue beat and next-quarter guidance above consensus midpoint, combined with lower-than-average DIO, point to healthier demand and reduced inventory buildup risk.

02

Market read

This is a company-specific earnings and guidance update with explicit revenue, EPS, and inventory (DIO) metrics that can drive near-term positioning.

03

What to watch

The article omits margins, backlog, customer concentration, and cash flow details; traders may need those to judge whether the guidance implies durable demand or temporary strength.

Relevance 8/10Novelty 8/10Timing: post-Q2 earnings release, shares down 1.3% immediately after reporting

Background

Nova provides semiconductor manufacturing quality control systems; the article frames results around revenue growth, guidance, and inventory risk via DIO.

Company-level read

Ticker impact

$NVMIBullishMedium confidence
Context

Nova reported Q2 CY2026 revenue of $255M, up 15.9% YoY, and guided next-quarter revenue to $282M midpoint.

Expected impact

Likely near-term upside bias versus pre-report expectations, with follow-through dependent on whether the guidance is sustained.

Evidence & confidence

The article provides concrete Q2 results, next-quarter midpoint guidance, and DIO improvement (152, 30 days below 5-year average), which collectively reduce demand-inventory risk and support the upcycle narrative.

Market effects

Improving inventory/demand signals in semiconductor quality control can be read-across to equipment and process-control spending strength during the upcycle.

Limited direct regional impact; Nova is Israel-headquartered but the catalyst is company-specific results.

Supports the broader semiconductor capex and process-control demand narrative, though impact is incremental versus major foundry/equipment prints.

Counterpoint

The stock fell 1.3% right after the report, suggesting the market may have priced in the beat and focused on valuation or higher expectations not captured here.

Key entities

  • Nova

    NASDAQ-listed semiconductor quality control systems provider reporting Q2 results and next-quarter revenue guidance.

  • Wall Street estimates

    Analysts’ consensus used as the comparison for the revenue beat and guidance midpoint.

Related articles

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

$NVMIMed

Nova WMC™ Expanding Adoption Across the Most Advanced Packaging Processes

Nova (NASDAQ: NVMI) said a leading global foundry customer selected its Nova WMC™ platform as tool-of-record for multi-layer measurement in advanced packaging. The company expects the win to support multiple production flows and notes accelerating WMC™ adoption across memory and foundry customers. Nova cited modular design and nanometer-level large-area scanning throughput.

$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).

$RIVNMed

What Rivian And Lucid's Latest Earnings Say About The EV Startup Race

The article compares Rivian and Lucid after their 2021 IPOs, focusing on recent earnings. Lucid reported $405 million revenue in the quarter, with net loss widening to over $1 billion, and announced an “operational reset” tied to $1.4 billion cash savings in 2026, plus $3 billion liquidity. Rivian reported $1.66 billion revenue last quarter and raised 2026 delivery guidance to 65,000-70,000 vehicles.

$LNGMedAI 8/10

Cheniere Energy Q2 Earnings Call Highlights

Cheniere Energy’s Q2 earnings call said updated guidance includes about $300 million from additional expected production, with Corpus Christi Stage 3 over 98% complete and Train 7 entering commissioning. The company signed a roughly $4.7 billion EPC contract for Sabine Pass Phase I, targeting FID in early next year. Cheniere repurchased 2.2 million shares for $550 million and declared a $0.555 dividend.